tiprankstipranks
TipRanksTop Financial ExpertsInsidersMark Foletta

Mark Foletta Insider Profile

4 Followers
Mark Foletta, Director at Dexcom, holds 55.18K shares in Dexcom (Ticker: DXCM), holds 0.00 shares in Biocept (Ticker: BIOCQ), holds 17.92K shares in AMN Healthcare Services (Ticker: AMN).
See the Hottest Stocks Based on Insider Trading >
tipranks
Mark Foletta

Mark Foletta
Dexcom (DXCM)
Director

Ranked #101,589 out of 109,030 Corporate Insiders

Profitable Transactions

18%
2 out of 11 Profitable Transactions

Average Return

-32.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$5M
88.47%
11.53%
0.00%
0.00%
A breakdown of Mark Foletta's holdings
See the Top Stocks by Insiders

Insider Roles

Dexcom
(DXCM)
Director
AMN Healthcare Services
(AMN)
Director
Biocept
(BIOCQ)
Interim CFO
Enanta Pharmaceuticals
(ENTA)
Director
Roles that Mark Foletta holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Dexcom
(DXCM)
Rating:Informative Sell
Date:Sep 09, 2016 - Sep 09, 2017
Return:+23.30%
The most profitable trade made by Mark Foletta
See the Latest Stocks Traded by Insiders

Mark Foletta's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
DXCM
Dexcom
Aug 04, 2026
Director
Uninformative Sell
330.64K
$4.58M
BIOCQ
Biocept
―
Interim CFO
―
―
FBRX
Forte Biosciences
May 29, 2019
―
Uninformative Buy
21.45K
$1.16M
ENTA
Enanta Pharmaceuticals
―
Director
―
―
RGLS
Regulus
Dec 06, 2017
―
Uninformative Buy
64.00K
$668.39K
AMN
AMN Healthcare Services
Jun 17, 2026
Director
Uninformative Sell
114.33K
$597.35K
~AMBI
Ambit
―
―
―
―
List of latest transactions for each holding click on a transaction to see Mark Foletta's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Mark Foletta insider profile FAQ

What is the percentage of profitable transactions made by Mark Foletta?
The percentage of profitable transactions made by Mark Foletta is 18%.
    What is the average return per transaction made by Mark Foletta?
    The average return per transaction made by Mark Foletta is -32.30%.
      What stocks does Mark Foletta hold?
      Mark Foletta holds: DXCM, BIOCQ, FBRX, ENTA, RGLS, AMN, ~AMBI stocks.
        What was Mark Foletta’s latest transaction?
        Mark Foletta latest transaction was an Uninformative Sell of $330.64K.
          What was Mark Foletta's most profitable transaction?
          Mark Foletta’s most profitable transaction was an Informative Sell of DXCM stock on September 9, 2016. The return on the trade was 23.30%.
            What is Mark Foletta's role in Dexcom?
            Mark Foletta's role in Dexcom is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.